Hong Kong rugby player and cancer survivor on why screening is key even for young and fitOctober 16, 2026
General invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journalBy Healthcare Propulsion StaffOctober 16, 20260 invIOs GmbH (“invIOs”), a privately held biotechnology company developing innovative cancer immunotherapies, today announced the publication of new clinical data…
